TMCnet News

Research and Markets: Global Glaucoma Pipeline Highlights - 2014 Research Report
[January 07, 2014]

Research and Markets: Global Glaucoma Pipeline Highlights - 2014 Research Report


DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/sf53h4/global_glaucoma) has announced the addition of the "Global Glaucoma Pipeline Highlights - 2014" report to their offering.

The latest report Glaucoma Pipeline Highlights - 2014, provides most up-to-date information on key pipeline molecules in the global glaucoma market. It covers emerging therapies for glaucoma in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides glaucoma pipeline molecules by clinical trial stages including both early and late stage development - phase 3clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.



Drug Mechanism Classes:

The report provides glaucoma pipeline molecules by their dominant mechanism of action. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.


Company:

The report provides glaucoma pipeline molecules by the Originator Company.

Short-term Launch Highlights:

Find out which glaucoma pipeline products will be launched in the US and Ex-US till 2017.

Summary:

- Glaucoma phase 3 clinical trial pipeline molecules

- Glaucoma phase 2 clinical trial pipeline molecules

- Glaucoma phase 1 clinical trial pipeline molecules

- Glaucoma preclinical research pipeline molecules

- Glaucoma discovery stage pipeline molecules

- Glaucoma pipeline molecules short-term launch highlights

Key Topics Covered:

1. Glaucoma Pipeline by Stages

2. Glaucoma Pipeline by Drug Class

3. Glaucoma Pipeline by Company

4. Glaucoma Phase 3 Clinical Trial Insights

5. Glaucoma Phase 2 Clinical Trial Insights

6. Glaucoma Phase 1 Clinical Trial Insights

7. Glaucoma Preclinical Research Insights

8. Glaucoma Discovery Stage Insights

9. Appendix

10. Research Methodology

Tables

Figures

For more information visit http://www.researchandmarkets.com/research/sf53h4/global_glaucoma

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


[ Back To TMCnet.com's Homepage ]